Profile data is unavailable for this security.
About the company
Sinotherapeutics Inc is China-based company mainly engaged in the research and development, commercial production and sales of pharmaceutical preparations. The Company's main businesses include research and development, production and sales of generic drugs, as well as contract research and development organization (CRO) services. The Company mainly operates in the domestic market and overseas markets.
- Revenue in CNY (TTM)449.12m
- Net income in CNY109.57m
- Incorporated2012
- Employees260.00
- LocationSinotherapeutics IncSHANGHAI 201210ChinaCHN
- Phone+86 2 168819009
- Fax+86 2 168819009
- Websitehttps://www.sinotherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Jibeier Pharmaceutical Co Ltd | 887.17m | 238.58m | 5.25bn | 1.45k | 21.01 | 2.33 | -- | 5.92 | 1.25 | 1.25 | 4.64 | 11.31 | 0.3848 | 2.99 | 3.78 | 613,955.40 | 10.34 | 9.77 | 11.16 | 10.66 | 87.99 | 88.44 | 26.86 | 23.29 | 9.03 | -- | 0.0014 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.76bn | 272.96m | 5.39bn | 1.69k | 19.67 | 3.38 | -- | 3.06 | 0.6244 | 0.6244 | 4.05 | 3.63 | 0.5513 | 1.43 | 6.70 | 1,044,835.00 | 8.34 | 5.39 | 14.83 | 9.37 | 69.28 | 66.91 | 15.12 | 8.95 | 0.4736 | -- | 0.3161 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.82bn | 112.88m | 5.53bn | 2.47k | 49.02 | 4.79 | -- | 3.04 | 0.2821 | 0.2821 | 4.55 | 2.89 | 0.6323 | 2.49 | 3.22 | 737,841.70 | 4.09 | 5.81 | 6.24 | 9.78 | 53.91 | 58.01 | 6.48 | 7.03 | 0.7573 | 12.48 | 0.5316 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
| Shanghai Haixin Group Co Ltd | 841.27m | 178.76m | 5.59bn | 760.00 | 41.73 | 1.71 | -- | 6.65 | 0.1481 | 0.1481 | 0.697 | 3.62 | 0.1607 | 5.09 | 6.89 | 1,106,933.00 | 4.06 | 2.68 | 4.52 | 3.06 | 52.44 | 44.55 | 25.25 | 11.17 | 3.01 | -- | 0.0077 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
| Shanghai Hile Bio-Technology Co Ltd | 220.55m | 8.35m | 5.70bn | 295.00 | 748.49 | 4.48 | -- | 25.83 | 0.0116 | 0.0116 | 0.337 | 1.93 | 0.1379 | 1.26 | 2.06 | 747,619.90 | 0.0221 | 1.73 | 0.0278 | 2.47 | 48.68 | 50.44 | 0.1606 | 10.37 | 2.92 | -- | 0.0504 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
| Sinotherapeutics Inc | 449.12m | 109.57m | 5.70bn | 260.00 | 52.05 | 4.61 | -- | 12.70 | 0.2417 | 0.2417 | 0.9907 | 2.73 | 0.3228 | 2.50 | 5.20 | 1,727,366.00 | 7.88 | -- | 8.54 | -- | 53.66 | -- | 24.40 | -- | 7.95 | -- | 0.00002 | -- | 21.13 | -- | -34.29 | -- | -- | -- |
| Guizhou Sanli Pharmaceutical Co Ltd | 2.11bn | 328.87m | 5.94bn | 2.28k | 18.58 | 3.71 | -- | 2.81 | 0.7798 | 0.7798 | 5.05 | 3.91 | 0.8372 | 2.90 | 4.48 | 925,761.20 | 13.32 | 12.39 | 19.88 | 16.72 | 69.37 | 70.45 | 15.91 | 16.31 | 1.62 | -- | 0.2373 | 25.70 | 36.10 | 17.75 | 45.42 | 21.51 | 127.48 | -- |
Data as of Nov 12 2024. Currency figures normalised to Sinotherapeutics Inc's reporting currency: Chinese Yuan Renminbi CNY
4.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 1.86m | 4.33% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 49.10k | 0.11% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 43.70k | 0.10% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 33.05k | 0.08% |
| E Fund Management Co., Ltd.as of 30 Sep 2024 | 15.09k | 0.04% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 12.04k | 0.03% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 8.03k | 0.02% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 7.16k | 0.02% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2024 | 7.16k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 5.93k | 0.01% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
